Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial
Background. Chloroquine (CQ) remains the treatment of choice for Plasmodium vivax malaria. Initially confined to parts of Indonesia and Papua, resistance of P. vivax to CQ seems to be spreading, and alternative treatments are required. Methods. We conducted a randomized controlled study to compare t...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/12219 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.12219 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.122192018-05-03T15:22:47Z Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial Aung Pyae Phyo Khin Maung Lwin Ric N. Price Elizabeth A. Ashley Bruce Russell Kanlaya Sriprawat Niklas Lindegardh Pratap Singhasivanon Nicholas J. White François Nosten Shoklo Malaria Research Unit Mahidol University Menzies School of Health Research Nuffield Department of Clinical Medicine Agency for Science, Technology and Research, Singapore Medicine Background. Chloroquine (CQ) remains the treatment of choice for Plasmodium vivax malaria. Initially confined to parts of Indonesia and Papua, resistance of P. vivax to CQ seems to be spreading, and alternative treatments are required. Methods. We conducted a randomized controlled study to compare the efficacy and the tolerability of CQ and dihydroartemisinin-piperaquine (DP) in 500 adults and children with acute vivax malaria on the Northwestern border of Thailand. Results. Both drugs were well tolerated. Fever and parasite clearance times were slower in the CQ than in the DP group (P < . 001). By day 28, recurrent infections had emerged in 18 of 207 CQ recipients compared with 5 of 230 treated with DP (relative risk, 4.0; 95% confidence interval [CI], 1.51-10.58; P =. 0046). The cumulative risk of recurrence with P. vivax at 9 weeks was 79.1% (95% CI, 73.5%-84.8%) in patients treated with CQ compared with 54.9% (95% CI, 48.2%-61.6%) in those receiving DP (hazard ratio [HR] , 2.27; 95% CI, 1.8-2.9; P < . 001). Children < 5 years old were at greater risk of recurrent P. vivax infection (74.4%; 95% CI, 63.2%-85.6%) than older patients (55.3% [95% CI, 50.2%-60.4%]; HR, 1.58 [95% CI, 1.1-2.2] ; P =. 005). In vitro susceptibility testing showed that 13% of the tested isolates had a CQ median inhibitory concentration > 100 nmol/L, suggesting reduced susceptibility. Conclusions. The efficacy of CQ in the treatment of P. vivax infections is declining on the Thai-Myanmar border. DP is an effective alternative treatment. © 2011 The Author Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. 2018-05-03T08:22:47Z 2018-05-03T08:22:47Z 2011-11-15 Review Clinical Infectious Diseases. Vol.53, No.10 (2011), 977-984 10.1093/cid/cir631 15376591 10584838 2-s2.0-80054767617 https://repository.li.mahidol.ac.th/handle/123456789/12219 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80054767617&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Medicine |
spellingShingle |
Medicine Aung Pyae Phyo Khin Maung Lwin Ric N. Price Elizabeth A. Ashley Bruce Russell Kanlaya Sriprawat Niklas Lindegardh Pratap Singhasivanon Nicholas J. White François Nosten Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial |
description |
Background. Chloroquine (CQ) remains the treatment of choice for Plasmodium vivax malaria. Initially confined to parts of Indonesia and Papua, resistance of P. vivax to CQ seems to be spreading, and alternative treatments are required. Methods. We conducted a randomized controlled study to compare the efficacy and the tolerability of CQ and dihydroartemisinin-piperaquine (DP) in 500 adults and children with acute vivax malaria on the Northwestern border of Thailand. Results. Both drugs were well tolerated. Fever and parasite clearance times were slower in the CQ than in the DP group (P < . 001). By day 28, recurrent infections had emerged in 18 of 207 CQ recipients compared with 5 of 230 treated with DP (relative risk, 4.0; 95% confidence interval [CI], 1.51-10.58; P =. 0046). The cumulative risk of recurrence with P. vivax at 9 weeks was 79.1% (95% CI, 73.5%-84.8%) in patients treated with CQ compared with 54.9% (95% CI, 48.2%-61.6%) in those receiving DP (hazard ratio [HR] , 2.27; 95% CI, 1.8-2.9; P < . 001). Children < 5 years old were at greater risk of recurrent P. vivax infection (74.4%; 95% CI, 63.2%-85.6%) than older patients (55.3% [95% CI, 50.2%-60.4%]; HR, 1.58 [95% CI, 1.1-2.2] ; P =. 005). In vitro susceptibility testing showed that 13% of the tested isolates had a CQ median inhibitory concentration > 100 nmol/L, suggesting reduced susceptibility. Conclusions. The efficacy of CQ in the treatment of P. vivax infections is declining on the Thai-Myanmar border. DP is an effective alternative treatment. © 2011 The Author Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. |
author2 |
Shoklo Malaria Research Unit |
author_facet |
Shoklo Malaria Research Unit Aung Pyae Phyo Khin Maung Lwin Ric N. Price Elizabeth A. Ashley Bruce Russell Kanlaya Sriprawat Niklas Lindegardh Pratap Singhasivanon Nicholas J. White François Nosten |
format |
Review |
author |
Aung Pyae Phyo Khin Maung Lwin Ric N. Price Elizabeth A. Ashley Bruce Russell Kanlaya Sriprawat Niklas Lindegardh Pratap Singhasivanon Nicholas J. White François Nosten |
author_sort |
Aung Pyae Phyo |
title |
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial |
title_short |
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial |
title_full |
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial |
title_fullStr |
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial |
title_full_unstemmed |
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial |
title_sort |
dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in thailand: a randomized controlled trial |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/12219 |
_version_ |
1763489769902309376 |